Evidence map›Paper›PMID 33854442›Full record

ArticleFrontiers in physiology2021

Alteration of DNA Damage Response Causes Cleft Palate.

Hiroyuki Yamaguchi, Kohei Kitami, Xiao Wu, Li He, Jianbo Wang, Bin Wang, Yoshihiro Komatsu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hiroyuki YamaguchiDepartment of Pediatrics, The University of Texas Medical School at Houston, Houston, TX, United States.
Kohei KitamiDepartment of Pediatrics, The University of Texas Medical School at Houston, Houston, TX, United States.
Xiao WuDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Li HeDepartment of Pediatrics, The University of Texas Medical School at Houston, Houston, TX, United States.
Jianbo WangDepartment of Pediatrics, The University of Texas Medical School at Houston, Houston, TX, United States.
Bin WangDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Yoshihiro KomatsuDepartment of Pediatrics, The University of Texas Medical School at Houston, Houston, TX, United States.
The University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Houston · US

Funding

The role of a novel BRCA1 associated complex in DNA damage response and tumor supR01CA155025 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WANG, BIN · 2011 to 2020
$3.4M
The role of BMP signaling in craniofacial cartilage developmentR01DE025897 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOMATSU, YOSHIHIRO · 2017 to 2021
$1.8M
Coordination of DNA repair and transcription by ubiquitin modification at DNA double strand breaksR01CA248088 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WANG, BIN · 2020 to 2024
$1.8M
NCI NIH HHS R01 CA155025NCI NIH HHS R01 CA248088NIDCR NIH HHS R01 DE025897
6 · The paper itself

Abstract

Cleft palate is one of the most common craniofacial birth defects, however, little is known about how changes in the DNA damage response (DDR) cause cleft palate. To determine the role of DDR during palatogenesis, the DDR process was altered using a pharmacological intervention approach. A compromised DDR caused by a poly (ADP-ribose) polymerase (PARP) enzyme inhibitor resulted in cleft palate in wild-type mouse embryos, with increased DNA damage and apoptosis. In addition, a mouse genetic approach was employed to disrupt breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2), known as key players in DDR. An ectomesenchymal-specific deletion of

Indexed as

BRCA1BRCA2cleft palateDNA damage responsepoly (ADP-ribose) polymerase inhibitor

Identifiers

PMID33854442
PMCPMC8039291
OpenAlexW3148011779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.